The biotech drug developer posted revenue of $571,400 in the period. Its adjusted revenue was $571,000. The company's shares closed at 80 cents.
News
- Salarius: Q2 Earnings Snapshot
- Calithera: Q2 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) _ Calithera Biosciences Inc. (CALA) on Thursday reported a loss of $14.3 million in its second quarter.
- NGM Biopharmaceuticals: Q2 Earnings Snapshot
The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share. The biotechnology company posted ...
- Fate Therapeutics: Q2 Earnings Snapshot
The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share. The clinical-stage biotech company ...
- Entrepreneurs Disrupt Wasteful Supply Chain Practices
This fact was simply unacceptable to the founders of Strella Biotech. They created technology to essentially “hack fruit.” With sensors, IoT networks and ...